RIGEL PHARMACEUTICALS INC logo

RIGEL PHARMACEUTICALS INC

1034842

Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Key products include TAVALISSE and REZLIDHIA. The company is positioned as an innovator in hematology and oncology.

79
Vertrauenswürdig
Vertrauensscore

Offizielles Register

Rechtlicher Name
RIGEL PHARMACEUTICALS INC
Organisationsnummer
0001034842
Unternehmensstatus
Active
Branchencodes
2834: Pharmaceutical Preparations

Zuletzt überprüft: 12/30/2025

KI-Qualitätsanalyse

Branche
Biotechnology
SSL/HTTPS
Sicher
Professionelle E-Mail
Ja
Kontakt E-Mail
ir@rigel.com

Vertrauensscore-Details

Register verifiziert35/35
Qualitätsbewertung44/60
Nachrichtenstimmung0/5

Schnellzugriff

Zuletzt aktualisiert: 12/30/2025

🌟 Ähnliche vertrauenswürdige Unternehmen

Cidara Therapeutics, Inc.

Cidara Therapeutics, Inc. logo
80/100 · Sehr Vertrauenswürdig

Cidara Therapeutics develops targeted immunotherapies to save lives and improve the standard of care for patients facing serious diseases. Their Cloudbreak platform creates “single molecule cocktails” designed to inhibit specific disease targets while engaging the immune system. Noted as a Top Place to Work for six years.

USA
Profil ansehen

Alpha Teknova, Inc.

Alpha Teknova, Inc. logo
74/100 · Vertrauenswürdig

This company provides a range of solutions and products, mainly focused on AAV (Adeno-Associated Virus) technologies, including PCR sample preparation kits, stabilizers, and AEX buffer screening kits. They also offer a variety of agar plates, bacterial and fungal culture media, buffers, reagents, and cryopreservation media for biological research. Their products are utilized in molecular biology, cell culture, and related scientific fields. They offer RUO and GMP grade products.

USA
Profil ansehen

Protalix BioTherapeutics, Inc.

Protalix BioTherapeutics, Inc. logo
71/100 · Vertrauenswürdig

Protalix is dedicated to bringing to market recombinant therapeutic proteins with clinically improved profiles, produced with their ProCellEx® plant cell-based expression system. They focus on treating rare diseases and have already launched two enzyme replacement therapies. The company is known for its innovative ProCellEx® technology.

USA
Profil ansehen